Rerouting Drug Supplies ‘A Priority’ After Brexit Transition Ends
Industry Again Urged To Stockpile To Mitigate Blockages
Pharmaceutical companies in the UK have again been asked to ensure they have contingency measures in place to deal with potential supply problems at channel ports – this time in preparation for the UK’s formal departure from the EU’s single market and customs union at the beginning of 2021. The industry is continuing to push for a mutual recognition agreement on drug regulation.
